| PTC124 for Cystic Fibrosis (NCT00234663) | PTC Therapeutics | 2005-09-01 |
| Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Subjects (NCT00125346) | Novartis | 2005-09-01 |
| A Study in Pediatric Patients With Cystic Fibrosis Lung Disease (NCT00130182) | Merck Sharp & Dohme LLC | 2005-08-01 |
| Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA) (NCT00128492) | Gilead Sciences | 2005-08-01 |
| Study on the Efficacy of Slow Release Insulin in Cystic Fibrosis Patients With Glucide Intolerance and Clinical Decay (NCT00687466) | Fondazione per la ricerca sulla Fibrosi Cistica | 2005-08-01 |
| Using Health-related Quality of Life (HRQL) in Routine Clinical Care (NCT00457301) | University of Alberta | 2005-07-01 |
| An Effectiveness, Safety, and Palatability Study of Pancrelipase Microtablets in Infants and Toddlers With Cystic Fibrosis and Fat Malabsorption (NCT00217204) | McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | 2005-07-01 |
| Whole Body Vibration - a New Therapeutic Approach to Improve Muscle Function in CF (NCT00388466) | University of Cologne | 2005-06-01 |
| International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa (NCT00112359) | Gilead Sciences | 2005-05-01 |
| Effect of Non-Invasive Ventilation in Cystic Fibrosis Patient With Chronic Respiratory Failure. (NCT00208078) | Cochin Hospital | 2005-05-01 |
| Safety Study of Orally Administered Curcuminoids in Adult Subjects With Cystic Fibrosis (NCT00219882) | Ramsey, Bonnie, MD | 2005-04-01 |
| Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA (NCT00585364) | University of Pittsburgh | 2005-03-01 |
| Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa (NCT00104520) | Gilead Sciences | 2005-02-01 |
| EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection (NCT00105183) | Neovii Biotech | 2005-01-01 |
| Effectiveness of Pulmozyme in Infants With Cystic Fibrosis (NCT00179998) | Nationwide Children's Hospital | 2005-01-01 |
| The EPIC Observational Study (NCT00676169) | CF Therapeutics Development Network Coordinating Center | 2004-10-01 |
| Multi Breath Nitrogen Washout (MBNW) as a Measure of Small Airway Function in Patients With Respiratory Disease (NCT00163696) | Bayside Health | 2004-09-01 |
| Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group (NCT00221559) | University Hospital, Ghent | 2004-09-01 |
| Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation (NCT00129350) | Royal Brompton & Harefield NHS Foundation Trust | 2004-09-01 |
| Assessment of Inflammatory Mediators (AIM) (NCT00219895) | Ramsey, Bonnie, MD | 2004-08-01 |
| Effect of Simvastatin on CF Airway Inflammation (NCT00255242) | Akron Children's Hospital | 2004-07-01 |
| Safety and Tolerability of Inhaled Nitric Oxide in Patients With Cystic Fibrosis (NCT00570349) | Mallinckrodt | 2004-07-01 |
| Comparison of Antibiotics for Pseudomonas in Early CF (NCT00823238) | University of North Carolina, Chapel Hill | 2004-07-01 |
| Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiency (NCT00095732) | Anthera Pharmaceuticals | 2004-06-01 |
| Non-Invasive Biomarkers in Cystic Fibrosis (NCT00413140) | Maastricht University Medical Center | 2004-06-01 |
| Alpha1 Antitrypsin Aerosol Therapy in Cystic Fibrosis (NCT02010411) | Université de Sherbrooke | 2004-06-01 |
| Single Dose Escalation Study of TR02 (Sustained Lipid Inhalation Technology [SLIT™] Amikacin) in Participants With Cystic Fibrosis (CF) Having Chronic Infections of Pseudomonas Aeruginosa (NCT06238856) | Insmed Incorporated | 2004-05-12 |
| Zinc Homeostasis and Kinetics in Children With Cystic Fibrosis (CF) (NCT00104494) | Cystic Fibrosis Foundation | 2004-05-01 |
| Effects of 5-Methyltetrahydrofolate and Vitamin B12 Supplemetation on Red Cell Membrane in Children With Cystic Fibrosis (NCT00730509) | Universita di Verona | 2004-04-01 |
| A Phase 2 Study to Determine the Safety and Efficacy of Inhaled Dry Powder Mannitol in Cystic Fibrosis (NCT00455130) | Syntara | 2004-03-01 |
| Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF) (NCT00153634) | Seattle Children's Hospital | 2004-03-01 |
| Genetic Modifiers of Cystic Fibrosis (CF) Liver Disease (NCT00804583) | University of North Carolina, Chapel Hill | 2004-03-01 |
| An Interactive Program to Improve Care for Children With CF (NCT00185549) | Stanford University | 2004-03-01 |
| Treatment of Metabolic Alkalosis in Acute Exacerbations of Cystic Fibrosis (NCT00163852) | Bayside Health | 2004-02-01 |
| Mucin in Sputum of CF During Pulmonary Exacerbation (NCT00202072) | Philipps University Marburg | 2004-01-01 |
| Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients (NCT00157690) | McMaster University | 2003-12-01 |
| Deposition of Inhaled Prolastin in Cystic Fibrosis Patients (NCT00486837) | Grifols Therapeutics LLC | 2003-12-01 |
| Anti-pseudomonas IgY to Prevent Infections in Cystic Fibrosis (NCT00633191) | Immunsystem AB | 2003-11-01 |
| Efficacy and Safety of 28 or 56 Day Treatment for Pseudomonas Aeruginosa in Children With Cystic Fibrosis (NCT00391976) | Novartis | 2003-11-01 |
| Nasal Potential Difference (NPD) for the Diagnosis of Cystic Fibrosis (NCT00589745) | Children's Hospital of Philadelphia | 2003-09-01 |
| A Study to Evaluate Nutropin AQ for the Treatment of Growth Restriction in Children With Cystic Fibrosis (NCT00079742) | Genentech, Inc. | 2003-09-01 |
| Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection (NCT01055847) | Gilead Sciences | 2003-06-01 |
| Safety and Efficacy of Recombinant Adeno-Associated Virus Containing the CFTR Gene in the Treatment of Cystic Fibrosis (NCT00073463) | Targeted Genetics Corporation | 2003-06-01 |
| Efficacy and Safety of 24 Weeks of Oral Treatment With BIIL 284 BS in Adult and Pediatric Patients (NCT00060801) | Boehringer Ingelheim | 2003-05-01 |
| Investigating Mucinase Activity in Airway Disease (NCT00596232) | University of California, San Francisco | 2003-04-01 |
| Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung Disease (NCT00056147) | Merck Sharp & Dohme LLC | 2003-04-01 |
| Non-invasive Ventilation and Oxygen Therapy in Cystic Fibrosis Patients With Nocturnal Oxygen Desaturation (NCT00157183) | Bayside Health | 2003-03-01 |
| Use of Formula Fortified With DHA in Infants With Cystic Fibrosis (NCT00530244) | University of Massachusetts, Worcester | 2003-03-01 |
| Phenylbutyrate/Genistein Duotherapy in Delta F508-Heterozygotes (for Cystic Fibrosis) (NCT00590538) | Children's Hospital of Philadelphia | 2003-02-01 |
| Interest of Gentamicin-induced Readthrough in Cystic Fibrosis Patients (NCT00376428) | Assistance Publique - Hôpitaux de Paris | 2003-01-01 |
| Treatment of Low Bone Density in Cystic Fibrosis. (NCT01812551) | Istituto Auxologico Italiano | 2002-10-01 |
| Connexin Genotypes in Cystic Fibrosis (NCT04242420) | University Childrens' Hospital (Zentrum für Kinderheilkunde des Universitätsklinikum Bonn) | 2002-04-01 |
| Safety, Tolerability and Pharmacokinetics of BIIL 284 BS in Adult and Pediatric Cystic Fibrosis (CF) Patients (NCT02269189) | Boehringer Ingelheim | 2002-04-01 |
| Study of Interferon Gamma-1b by Injection for the Treatment of Patients With Cystic Fibrosis (NCT00043342) | InterMune | 2002-04-01 |
| Inhaled Bicarbonate Therapy in Cystic Fibrosis (NCT00177645) | University of Pittsburgh | 2002-03-01 |
| Prevalence and Treatment of Urinary Incontinence in Women With Cystic Fibrosis and Chronic Obstructive Pulmonary Disease (NCT00164138) | Bayside Health | 2001-12-01 |
| Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis (NCT00333385) | Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche | 2001-10-01 |
| Safety, Tolerability and Pharmacokinetics of Increasing Doses of BIIL 284 BS in Adult and Pediatric Cystic Fibrosis (CF) Patients (NCT02265679) | Boehringer Ingelheim | 2001-10-01 |
| Phenylbutyrate/Genistein Duotherapy in Delta F508-Homozygous(for Cystic Fibrosis) (NCT00016744) | Children's Hospital of Philadelphia | 2001-09-01 |
| Gene Modifiers of Cystic Fibrosis Lung Disease (NCT00037765) | University of North Carolina, Chapel Hill | 2001-09-01 |
| Genetic Modifiers of Cystic Fibrosis: Sibling Study (NCT00037778) | Johns Hopkins University | 2001-09-01 |
| Early Diagnosis of Diabetes Mellitus in Patients With Cystic Fibrosis (NCT00662714) | Mukoviszidose Institut gGmbH | 2001-09-01 |
| Comparison of 2 Treatment Regimens for Eradication of P Aeruginosa Infection in Children With Cystic Fibrosis (NCT01400750) | Universitaire Ziekenhuizen KU Leuven | 2001-08-01 |
| Efficacy of Amiloride and Hypertonic Saline in Cystic Fibrosis (NCT00274391) | University of North Carolina | 2001-07-01 |
| The Role of Bacteria and Genetic Variations in Cystic Fibrosis (NCT00043225) | National Heart, Lung, and Blood Institute (NHLBI) | 2001-06-20 |
| A Study in Adult and Pediatric Patients With Cystic Fibrosis (NCT00034515) | Merck Sharp & Dohme LLC | 2001-06-01 |
| Diabetes Therapy to Improve BMI and Lung Function in CF (NCT00072904) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2001-06-01 |
| Tissue Collection From People With Cystic Fibrosis (NCT00015756) | National Heart, Lung, and Blood Institute (NHLBI) | 2001-05-02 |
| Cystic Fibrosis Withdrawal of Inhaled Steroids Evaluation Study (CF WISE Study) (NCT00220259) | Royal Brompton & Harefield NHS Foundation Trust | 2001-05-01 |
| Phase II Study of Growth Hormone in Children With Cystic Fibrosis (NCT00016445) | University of Utah | 2001-02-01 |
| The Prevalence and Significance of Gastro-oesophageal Reflux in Cystic Fibrosis Before and After Lung Transplantation (NCT00164021) | Bayside Health | 2001-02-01 |
| Study of Metabolic Effects of Pregnancy in Women With Cystic Fibrosis (NCT00014768) | National Center for Research Resources (NCRR) | 2001-02-01 |
| Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis (NCT00043316) | InterMune | 2001-02-01 |
| Study of Hepatic Glucose Production and De Novo Lipogenesis in Patients With Cystic Fibrosis (NCT00014781) | University of Utah | 2001-02-01 |
| Macrolide Antibiotic Therapy for Patients With Cystic Fibrosis (NCT00205634) | Wake Forest University | 2000-12-01 |
| Effects of a 6-Months Physical Conditioning Program in Patients With Cystic Fibrosis (NCT00231686) | Julius-Maximilians University | 2000-11-01 |
| The Effects of Long Term Inhalation of Hypertonic Saline in Subjects With Cystic Fibrosis (NCT00271310) | Royal Prince Alfred Hospital, Sydney, Australia | 2000-09-01 |
| A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis (NCT00006280) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2000-02-01 |
| Growth Hormone Treatment Study in Children With Cystic Fibrosis (NCT00256555) | University of Texas Southwestern Medical Center | 2000-02-01 |
| A Study to Determine the Variability of a 6-Minute Walk Test in Cystic Fibrosis Subjects With Advanced Lung Disease (NCT00311506) | Genentech, Inc. | 1999-10-01 |
| Phase I Randomized Study of Adeno-Associated Virus-CFTR Vector in Patients With Cystic Fibrosis (NCT00004533) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1999-08-01 |
| Should Any One Airway Clearance Technique be Recommended for People With Cystic Fibrosis? (NCT00890370) | Royal Brompton & Harefield NHS Foundation Trust | 1999-07-01 |
| Randomized Study of Pancrelipase With Bicarbonate (PANCRECARB) Capsules in Reducing Steatorrhea in Patients With Cystic Fibrosis (NCT00006063) | National Center for Research Resources (NCRR) | 1999-07-01 |
| Tissue Bank for Pulmonary Diseases (NCT00546962) | Boston Children's Hospital | 1999-04-01 |
| Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis (NCT00004489) | University of North Carolina | 1998-10-01 |
| Role of Toxins in Lung Infections Caused by Pseudomonas Aeruginosa (NCT00027183) | National Heart, Lung, and Blood Institute (NHLBI) | 1998-03-17 |
| Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis (NCT00004441) | Children's Hospital Medical Center, Cincinnati | 1997-09-01 |
| Phase I Randomized Study of CPX for the Treatment of Adult Patients With Mild Cystic Fibrosis (NCT00004428) | FDA Office of Orphan Products Development | 1997-09-01 |
| Study of Uridine Triphosphate (UTP) as an Aerosol Spray for Cystic Fibrosis (NCT00004705) | FDA Office of Orphan Products Development | 1996-09-01 |
| Study of Ibuprofen to Preserve Lung Function in Patients With Cystic Fibrosis (NCT00004440) | FDA Office of Orphan Products Development | 1996-08-01 |
| Behavioral Treatment of Weight Gain in CF (NCT00006169) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1996-06-01 |
| Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic Fibrosis (NCT00006273) | National Center for Research Resources (NCRR) | 1996-06-01 |
| Phase I Study of the Third Generation Adenovirus H5.001CBCFTR in Patients With Cystic Fibrosis (NCT00004287) | National Center for Research Resources (NCRR) | 1995-11-01 |
| Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease (NCT00004315) | National Center for Research Resources (NCRR) | 1995-11-01 |
| Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis Patients (NCT00004296) | National Center for Research Resources (NCRR) | 1995-09-01 |
| Phase I Pilot Study of Gene Therapy for Cystic Fibrosis Using Cationic Liposome Mediated Gene Transfer (NCT00004471) | University of Alabama at Birmingham | 1995-08-01 |
| Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis (NCT00004747) | National Center for Research Resources (NCRR) | 1995-07-01 |
| Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis (NCT00004806) | University of Alabama at Birmingham | 1995-06-01 |
| Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis (NCT00004829) | FDA Office of Orphan Products Development | 1995-06-01 |
| Phase I Pilot Study of Ad5-CB-CFTR, an Adenovirus Vector Containing the Cystic Fibrosis Transmembrane Conductance Regulator Gene, in Patients With Cystic Fibrosis (NCT00004779) | National Center for Research Resources (NCRR) | 1993-01-01 |